AgriMarine on Tuesday announced that it signed an agreement with Pearl River Fisheries Research Institute for collaborative research, development and commercialization of vaccines for the prevention and treatment of various bacterial and viral diseases affecting coldwater fish.
The agreement will allow AgriMarine and Pearl River to combine their scientific expertise to develop fish vaccines not currently available in China. Pearl River, a branch of the Chinese Academy of Fisheries Science, will provide the technical expertise and equipment for the isolation and culture of various coldwater fish pathogens for the commercial production of corresponding vaccines.
AgriMarine’s science and technology committee will provide the knowledge to culturally and genetically manipulate such pathogens to derive vaccines and additionally advice on certification and registration of the vaccines for use in China.
“We are taking this initiative in China, not only terms of safeguarding the health of the fish in AgriMarine’s salmon rearing facilities in Benxi, but also to collaborate with the Chinese Government in providing assistance to all its cold water fisheries,” said Lawrence Albright, chair of AgriMarine’s science and technology development committee. “Pearl River possess excellent laboratories and scientific staff, and has world class manufacturing facilities in place to accelerate commercial production of vaccines.”
